News Digging > News > Drug developer’s $425m merger called off
Drug developer’s 5m merger called off
Drug developer's $425m merger called off,Jounce is to be takeover by Concentra Biosciences in which Tang Capital Partners is the controlling shareholder

Drug developer’s $425m merger called off

Jounce is to be takeover by Concentra Biosciences in which Tang Capital Partners is the controlling shareholder